Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62


cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.

Prakash H, Becker D, Böhme L, Albert L, Witzenrath M, Rosseau S, Meyer TF, Rudel T.

PLoS One. 2009 Aug 6;4(8):e6519. doi: 10.1371/journal.pone.0006519.


Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice.

Prakash H, Albrecht M, Becker D, Kuhlmann T, Rudel T.

J Biol Chem. 2010 Jun 25;285(26):20291-302. doi: 10.1074/jbc.M109.096297. Epub 2010 Apr 28.


STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.

Rothfuchs AG, Trumstedt C, Mattei F, Schiavoni G, Hidmark A, Wigzell H, Rottenberg ME.

J Immunol. 2006 Jun 1;176(11):6982-90.


Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.

Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, Wigzell H.

J Immunol. 1999 Mar 1;162(5):2829-36.


Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.

Tammiruusu A, Haveri A, Pascolo S, Lahesmaa R, Stevanovic S, Rammensee HG, Sarvas M, Puolakkainen M, Vuola JM.

Scand J Immunol. 2005 Aug;62(2):131-9.


Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.

Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D, Ceausu M, Une C, Levitsky V, Wigzell H.

J Immunol. 2000 May 1;164(9):4812-8.


Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM.

J Immunol. 2003 Dec 1;171(11):6187-97.


NF-kappaB and inhibitor of apoptosis proteins are required for apoptosis resistance of epithelial cells persistently infected with Chlamydophila pneumoniae.

Paland N, Rajalingam K, Machuy N, Szczepek A, Wehrl W, Rudel T.

Cell Microbiol. 2006 Oct;8(10):1643-55.


MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae.

Rodríguez N, Mages J, Dietrich H, Wantia N, Wagner H, Lang R, Miethke T.

Physiol Genomics. 2007 Jul 18;30(2):134-45. Epub 2007 Mar 20.


Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages.

Qiu H, Fan Y, Joyee AG, Wang S, Han X, Bai H, Jiao L, Van Rooijen N, Yang X.

J Immunol. 2008 Aug 1;181(3):2092-102.


IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection.

Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, Rottenberg ME.

J Immunol. 2001 Dec 1;167(11):6453-61.


Immunological basis for susceptibility and resistance to pulmonary blastomycosis in mouse strains.

Brummer E, Kethineni N, Stevens DA.

Cytokine. 2005 Oct 7;32(1):12-9. Epub 2005 Sep 23.


Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Gosselin D, DeSanctis J, Boulé M, Skamene E, Matouk C, Radzioch D.

Infect Immun. 1995 Sep;63(9):3272-8.


The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.

Cowley SC, Goldberg MF, Ho JA, Elkins KL.

J Infect Dis. 2008 Jul 15;198(2):284-92. doi: 10.1086/589620.


Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1.

Grassmé H, Jin J, Wilker B, von Kürthy G, Wick W, Weller M, Möröy T, Gulbins E.

Cell Microbiol. 2006 Jul;8(7):1096-105.


IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells.

Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, Oswald M, Machuy N, Rudel T.

PLoS Pathog. 2006 Oct;2(10):e114.


Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae.

Costa CP, Kirschning CJ, Busch D, Dürr S, Jennen L, Heinzmann U, Prebeck S, Wagner H, Miethke T.

Eur J Immunol. 2002 Sep;32(9):2460-70.

Supplemental Content

Support Center